Artwork

Content provided by Labiotech. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Labiotech or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

New ways to treat Duchenne muscular dystrophy

23:56
 
Share
 

Manage episode 416154439 series 3361449
Content provided by Labiotech. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Labiotech or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Duchenne muscular dystrophy (DMD) is a genetic disorder with progressive muscle degeneration and weakness due to changes in the protein dystrophin, which helps keep muscle cells intact.

There are few treatments for DMD, although recent advances mean that males – who are primarily affected by DMD – can now sometimes survive into their 30s.
More drugs are being developed in the fight against DMD, and this week we had a conversation with Frank Gleeson, CEO of Satellos Bioscience, about recent work on addressing DMD, including the company’s own work in the field.

00:47-02:01: About Satellos Bioscience
02:01-04:33: What is Duchenne muscular dystrophy?
04:33-05:43: What are the challenges in treating Duchenne muscular dystrophy?
05:43-09:08: What are the new treatments for Duchenne muscular dystrophy?
09:08-11:20: What is your treatment for Duchenne muscular dystrophy?
11:20-13:42: Are there different approaches to treating Duchenne muscular dystrophy?
13:42-14:06: How is your treatment delivered?
14:06-17:32: How important is early intervention?
17:32-18:56: Where is Satellos at with clinical trials?
18:56-20:41: Preclinical trial results
20:41-21:44: Outreach to the Duchenne muscular dystrophy community
21:44-23:12: Is a cure for Duchenne muscular dystrophy possible?

Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here!

Stay updated by subscribing to our newsletter

  continue reading

Chapters

1. New ways to treat Duchenne muscular dystrophy (00:00:00)

2. About Satellos Bioscience (00:00:47)

3. What is Duchenne muscular dystrophy?
 (00:02:01)

4. What are the challenges in treating Duchenne muscular dystrophy?
 (00:04:33)

5. What are the new treatments for Duchenne muscular dystrophy? (00:05:43)

6. What is your treatment for Duchenne muscular dystrophy?
 (00:09:08)

7. Are there different approaches to treating Duchenne muscular dystrophy?
 (00:11:20)

8. How is your treatment delivered? (00:13:42)

9. How important is early intervention? (00:14:06)

10. Where is Satellos at with clinical trials?
 (00:17:32)

11. Preclinical trial results
 (00:18:56)

12. Outreach to the Duchenne muscular dystrophy community
 (00:20:41)

13. Is a cure for Duchenne muscular dystrophy possible? (00:21:44)

104 episodes

Artwork
iconShare
 
Manage episode 416154439 series 3361449
Content provided by Labiotech. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Labiotech or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Duchenne muscular dystrophy (DMD) is a genetic disorder with progressive muscle degeneration and weakness due to changes in the protein dystrophin, which helps keep muscle cells intact.

There are few treatments for DMD, although recent advances mean that males – who are primarily affected by DMD – can now sometimes survive into their 30s.
More drugs are being developed in the fight against DMD, and this week we had a conversation with Frank Gleeson, CEO of Satellos Bioscience, about recent work on addressing DMD, including the company’s own work in the field.

00:47-02:01: About Satellos Bioscience
02:01-04:33: What is Duchenne muscular dystrophy?
04:33-05:43: What are the challenges in treating Duchenne muscular dystrophy?
05:43-09:08: What are the new treatments for Duchenne muscular dystrophy?
09:08-11:20: What is your treatment for Duchenne muscular dystrophy?
11:20-13:42: Are there different approaches to treating Duchenne muscular dystrophy?
13:42-14:06: How is your treatment delivered?
14:06-17:32: How important is early intervention?
17:32-18:56: Where is Satellos at with clinical trials?
18:56-20:41: Preclinical trial results
20:41-21:44: Outreach to the Duchenne muscular dystrophy community
21:44-23:12: Is a cure for Duchenne muscular dystrophy possible?

Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here!

Stay updated by subscribing to our newsletter

  continue reading

Chapters

1. New ways to treat Duchenne muscular dystrophy (00:00:00)

2. About Satellos Bioscience (00:00:47)

3. What is Duchenne muscular dystrophy?
 (00:02:01)

4. What are the challenges in treating Duchenne muscular dystrophy?
 (00:04:33)

5. What are the new treatments for Duchenne muscular dystrophy? (00:05:43)

6. What is your treatment for Duchenne muscular dystrophy?
 (00:09:08)

7. Are there different approaches to treating Duchenne muscular dystrophy?
 (00:11:20)

8. How is your treatment delivered? (00:13:42)

9. How important is early intervention? (00:14:06)

10. Where is Satellos at with clinical trials?
 (00:17:32)

11. Preclinical trial results
 (00:18:56)

12. Outreach to the Duchenne muscular dystrophy community
 (00:20:41)

13. Is a cure for Duchenne muscular dystrophy possible? (00:21:44)

104 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide